EP Biocomposites Ltd

AGM Details

• AGM held on 28 Sep 2026 at 04:00 PM in-person in Bicholim, Goa; record date 23 Sep 2026.

Resolutions and outcomes

• Resolution 1: Adopt Audited Financial Statements; passed with unanimous in-favour.
• Resolution 2: Reappointment of Managing Director by rotation; passed with unanimous in-favour.

Collaboration scope and parties

• Parties: EP Biocomposites as execution partner; Malligavad Foundation and Anand Malligavad as exclusive technical advisors.
• Geographic scope: Goa state and Konkan division, including coastal and northern districts.
• Consideration: no upfront monetary payment under the agreement.
• Rationale: collaboration supports water-body rejuvenation and expands the aqua division.
• Malligavad Foundation is a Section 8 company.

EP Biocomposites Limited trading window closes Oct 1, 2026; will reopen after 48 hours of dissemination of the half-year ended Sept 30, 2026 financial results

AGM Details

• Date/time/mode: Sept 28, 2026, 04:00 PM IST, physical meeting in Bicholim, Goa.
• Quorum: six members present; Scrutinizer and Company Secretary attended.
• E-voting window: Sept 24–27, 2026; cut-off date: Sept 23, 2026.
• Meeting concluded at 04:20 PM.

Resolutions & status

• Ordinary: Adoption of standalone financial statements for FY ended 31 March 2026.
• Ordinary: Re-appointment of MD Rajkumar Kamat, retiring by rotation.
• Voting results and scrutinizer's report to be intimated separately.

Contract award details

• Awarded 70 KLD MBBR STP order at Nerul.
• Contract value INR 92.04 Lakhs; execution by 30.04.2027.
• Awarding entity: Beleza by the Beach; domestic.
• Nature: Supply, Installation, Testing, Commissioning for STP.
• Status: ordinary course; disclosed under policy.
• No promoter group interest; not a related party transaction.
• Execution timeframe: by 30.04.2027.

AGM details

• Upcoming AGM; exact date, time, and mode not disclosed in filing.

Key themes from Chairman's Message

• Strategic pivot to Aqua, FRP, and Fire verticals.
• Highlights for the year include revenue growth and profitability improvement.
• Acquisition of factory premises approved by shareholders.
• O&M business expansion to create recurring revenue.
• Strategic partnership with IISc for wastewater treatment tech.

Purpose of disclosure

• Discloses AGM presentation and upcoming investor/analyst meetings.
• Schedule for investor/analyst meets will be disclosed as meetings are scheduled.

Financial highlights (FY26)

• FY2025-26 revenue from operations: ₹1,363.98 lakh.
• FY26 EBITDA ₹237.83 lakh and margin 17.43%.
• FY26 PAT ₹145.83 lakh; margin 10.69%.
• Two-year revenue growth ~19% to ₹1,363.98 lakh.
• Total income ₹1,378.10 lakh; operating expenses ₹1,140.27 lakh.

Balance sheet snapshot

• Total shareholders’ funds at 31-03-2026: ₹1,205.30 lakh.
• Total assets at 31-03-2026: ₹1,873.14 lakh.
• Share capital ₹168.15 lakh; reserves ₹1,037.15 lakh.